Get started
Work

Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial

Year: 2021
Type: article
DOI: 10.1016/j.ijrobp.2021.07.042
Authors: B. Movsas, J. Rodgers, M.A. Elshaikh, A.A. Martinez, G. Morton, D.J. Krauss, D. Yan, D.E. Citrin, B. Hershatter, J.M. Michalski, R.J. Ellis, V.S. Kavadi, E.M. Gore, G.S. Gustafson, C.A. Schulz, V. Velker, A.C. Olson, T.G. Karrison, H.M. Sandler, D.W. Bruner
Institutions: Henry Ford Health, Henry Ford Hospital, NRG Oncology, 21st Century Oncology (United States), University of Toronto, Sunnybrook Hospital, Odette Cancer Centre, Beaumont Health, Beaumont Hospital, Royal Oak, National Institutes of Health, National Cancer Institute, Winship Cancer Institute, Washington University in St. Louis, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, Medical College of Wisconsin, Columbia St. Mary's Hospital, Western University, London Health Sciences Centre, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Cedars-Sinai Medical Center, Emory University
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3208917612
FWCI: 0.143
Cites:
Cited by: 1
Related to: 10